chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Myalgia, Pain, Vaccination site pain
Clinical narrative: Soreness throughout body; Weak throughout body; Sore and tender at injection site; Muscles aches; Fatigue; This is a spontaneous report received from a non-contactable pharmacist, the patient. A 34-year-old non pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL3247) via an unspecified route of administration in the left arm on 18Mar2021 at 09:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have any known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via an unspecified route of administration in the left arm on 25Feb2021 at 14:30 as a single dose for COVID-19 immunisation. On 18Mar2021 at 22:00, the patient experienced sore and tender at injection site, muscles aches, soreness and weak throughout body and fatigue. Therapeutic measures were taken as a result of adverse events and included treatment with Tylenol. The clinical outcome of sore and tender at injection site, muscle aches, soreness throughout body, weak throughout body and fatigue were recovered on an unknown date in Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Cognitive disorder, Gait disturbance, Lethargy, Memory impairment
Clinical narrative: Extreme lethargic; neurological symptoms; balance off; stumbling; swollen tongue; memory issues; cognitive delays; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6205) via unspecified route of administration in the left arm on 07Mar2021 at 12:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA as reported), high blood pressure and high cholesterol. Concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme lethargic, neurological symptoms, balance off, stumbling, swollen tongue, memory issues and cognitive delays on 10Mar2021. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lethargic, neurological symptoms, loss of balance, stumbling, swollen tongue, memory impairment and cognitive disturbances was resolving at the time of this report.   No follow up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Neurological symptom, Swollen tongue
Clinical narrative: Extreme lethargic; neurological symptoms; balance off; stumbling; swollen tongue; memory issues; cognitive delays; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6205) via unspecified route of administration in the left arm on 07Mar2021 at 12:00 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA as reported), high blood pressure and high cholesterol. Concomitant medications were not reported. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced extreme lethargic, neurological symptoms, balance off, stumbling, swollen tongue, memory issues and cognitive delays on 10Mar2021. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lethargic, neurological symptoms, loss of balance, stumbling, swollen tongue, memory impairment and cognitive disturbances was resolving at the time of this report.   No follow up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash with raised bumps on chest, left breast, back of left arm and upper back.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 19Mar2021 at 09:45 (at the age of 59-years-old), as a single dose for COVID-19 immunisation. Medical history included lung disease, rheumatoid arthritis and lupus. The patient was allergic to Z-pak. Concomitant medications included mycophenolate (MANUFACTURER UNKNOWN), prednisone (MANUFACTURER UNKNOWN), PLAQUENIL, sulfamethoxazole (MANUFACTURER UNKNOWN), ACTON; all for unknown indication from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021, the patient experienced rash with raised bumps on chest, left breast, back of left arm and upper back. The rash does not itch. The rash was very tender to the touch. The patient did not receive any treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events rash with raised bumps on chest, left breast, back of left arm and upper back was not resolved.  No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: Lost smell; Lost taste; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old non pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: UNKNOWN) via unspecified route in the left arm on 06Mar2021 at 05:45 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Mar2021 at 15:00 the day after the first dose, the patient lost her smell and taste for approximately 24 hours. The patient did not receive any treatment for the adverse events. The clinical outcome of events lost smell and lost taste was resolved as on 08Mar2021.   Information about lot number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Viral test
Clinical narrative: Diarrhetic discharge beginning ~72 hours after injection, progressing after ~5 hours to intermittent diarrhea; This is a spontaneous report received from a contactable consumer, the patient. A 32-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: en6207) via an unspecified route of administration in the right arm on 18Mar2021 at 16:00 (at the age of 32-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included bupropion hcl xl (MANUFACTURER UNKNWON) 450 milligram(mg), fluoxetine (MANUFACTURER UNKNOWN) 80 mg and KELNOR from an unknown date for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Lab tests and procedures included nasal swab test on 17Mar2021 which was found to be negative. The patient experienced diarrhetic discharge which was started after 72 hours of vaccination on 21Mar2021 at 14:30 and it was progressing after 5 hours to intermittent diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of diarrhea was not resolved. No follow-up attempts possible. No further information expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Hypokinesia, Muscular weakness
Clinical narrative: arm weakness; Could not turn head/neck down or sideways.; neck soreness on side of shot; injection site/arm soreness,; Fever of 100.2; chills; severe headache; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via an unspecified route of administration in the left arm on 17Mar2021 at 08:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis and psoriasis. The patient had penicillin allergy. The concomitant medication included Nikki as birth control. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to vaccination, the patient had no symptoms associated for COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. On 17Mar2021 at 21:00, the patient experienced almost immediate neck soreness on side of shot. 12 hours post-shot (on 17Mar2021), the patient had injection site/arm soreness, fever of 100.2 (unit unspecified), chills and severe headache. The temperature returned to normal 24-hours post vaccine. Injection site/arm soreness gone 48 hours post-shot and headache (severe) lingered for about 96 hours post vaccine. 48 hours post shot, neck pain increased dramatically. 72 hours post-shot (on 20Mar2021), the severe neck pain was there, radiating through shoulder blade and collar bone and the patient could not turn head/neck down or sideways (spasms). 120 hours post-shot (on 22Mar2021), arm soreness returned with arm weakness. The neck pain was still present (130 hours post), but not as severe. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events fever was recovered on 18Mar2021 (24 hours post-shot), vaccination site pain was recovered on 19Mar2021 (48 hours post-shot), headache was recovered on 21Mar2021 (96 hours post-shot) and chills on an unknown date in Mar2021. At the time of this report, the patient was not recovered from the events neck pain, weakness on arm and could not turn head/neck down or sideways.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pyrexia, Vaccination site pain
Clinical narrative: arm weakness; Could not turn head/neck down or sideways.; neck soreness on side of shot; injection site/arm soreness,; Fever of 100.2; chills; severe headache; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via an unspecified route of administration in the left arm on 17Mar2021 at 08:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis and psoriasis. The patient had penicillin allergy. The concomitant medication included Nikki as birth control. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to vaccination, the patient had no symptoms associated for COVID-19. Since the vaccination, the patient was not tested positive for COVID-19. On 17Mar2021 at 21:00, the patient experienced almost immediate neck soreness on side of shot. 12 hours post-shot (on 17Mar2021), the patient had injection site/arm soreness, fever of 100.2 (unit unspecified), chills and severe headache. The temperature returned to normal 24-hours post vaccine. Injection site/arm soreness gone 48 hours post-shot and headache (severe) lingered for about 96 hours post vaccine. 48 hours post shot, neck pain increased dramatically. 72 hours post-shot (on 20Mar2021), the severe neck pain was there, radiating through shoulder blade and collar bone and the patient could not turn head/neck down or sideways (spasms). 120 hours post-shot (on 22Mar2021), arm soreness returned with arm weakness. The neck pain was still present (130 hours post), but not as severe. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events fever was recovered on 18Mar2021 (24 hours post-shot), vaccination site pain was recovered on 19Mar2021 (48 hours post-shot), headache was recovered on 21Mar2021 (96 hours post-shot) and chills on an unknown date in Mar2021. At the time of this report, the patient was not recovered from the events neck pain, weakness on arm and could not turn head/neck down or sideways.   No follow-up attempts are possible. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Nausea
Clinical narrative: Diarrhea; nausea; headache; This is a spontaneous report received from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) via an unspecified route administration in right arm on 19Mar2021 at 16:00 (at the age of 54-years-old) as a single dose, for COVID-19 immunisation. Medical history was reported as none. The patient had unspecified allergies to food, medications, or other products. The patient received unspecified medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On 20Mar2021 at 02:00, the patient experienced diarrhea, nausea and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures and treatments were not taken for the reported events. The clinical outcome of the events diarrhea, nausea and headache were not recovered at the time of this report.   No follow-up attempts are needed. No further information was expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Minor rash on trunk, some spots on upper arms and upper legs; This is a spontaneous report received from a contactable consumer, the patient. A 50-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534), via an unspecified route of administration in the left arm on 18Mar2021 at 16:00 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included sarcoidosis and asthma. The patient had no known allergies to medications, food, or other products. Concomitant medication included leflunomide (MANUFACTURER UNKNOWN), FLOVENT (fluticasone), lactobacillus acidophilus (ACIDOPHILUS), ospemifene (OSPHENA) and MULTIVI (MANUFACTURER UNKNOWN); all for unknown indications from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 07:00, the patient experienced minor rash on trunk, some spots on upper arms and upper legs. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The patient was treated with over-the-counter BENADRYL for the event. The clinical outcome of the minor rash on trunk, some spots on upper arms and upper legs was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Pain, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6206) via an unspecified route of administration on 17Mar2021, at 12:30 on left hand, as a single dose (at the age of 55 years) for COVID-19 immunisation. The patient medical history included asthma, hypertension, and high cholesterol. The patient was not allergic to medications, food, or other products. Concomitant medication included Irbersartan/ HCTZ (MANUFACTURER UNKNOWN) 150-12.5 mg and atorvastatin (MANUFACTURER UNKNOWN) strength 200 mg. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021, the patient experienced very sore arm the night of the injection and on 18Mar2021, the patient experienced headache, severe body ache and swollen lymph nodes which caused a lot of pain in my armpit until three days after injection. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of painful arm, headache, general body pains and swelling of lymph nodes was recovered. No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Hypoaesthesia, Hypoaesthesia oral, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report received from a contactable consumer, the patient. A 40-year-old female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown) via an unspecified route administration in the right arm on 12Mar2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient previously received levoquin Zithromax (Z-PAK) and echinacea (MANUFACTURER UNKNOWN) for unspecified indication and experienced drug allergy. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested positive for COVID-19. The patient underwent lab test and procedures, which included COVID-19 virus test on 22Mar2021 and tested negative. On16Mar2021, the patient experienced facial numbness on the outside of face and lasted 2-3 days, about a week after, the patient experienced numbness inside mouth and 9 days (20Mar2021) after the vaccine loss of taste, it was still present at the time of report. Therapeutic measures were not taken for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events facial numbness on the outside of face was resolved on an unknown date in Mar2021, while the clinical outcome of numbness inside mouth was unknown and loss of taste was not recovered at the time of report.   Information about lot number cannot be obtained. No further information is expected.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Hives; and itching all over body; This is a spontaneous report received from a non-contactable consumer. A 88 years-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on an unknown date in Mar2021 (at an age of 88-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included unspecified cholesterol medications from unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. On an unknown date in Mar2021, the patient experienced hives and itching all over the body. Therapeutic measures were taken as a result of the events and included treatment with steroids. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the hives and itching all over was resolving at the time of this report.   Information about lot number cannot be obtained. No further information expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Intermenstrual bleeding, Nausea, Vomiting
Clinical narrative: Menstrual spotting; Heavy period; Painful period; Nauseous; Vomited; This is a spontaneous report from a non-contactable consumer, the patient. A 30 years old non pregnant female patient received the first dose of BNT162b2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, Lot number: unknown) via an unspecified route of administration on the left arm on 15Mar2021 at 14:30 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received SSRI (as reported) for unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not tested positive for COVID-19. On 17Mar2021 at 14:00, the patient experienced menstrual spotting after her shot, and patient period was 3 days early. The patient period had been very heavy and very painful and patient had never experienced a period like that before. The patient had felt nauseous and had vomited. The adverse events resulted in a doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events menstrual spotting, early period, heavy period, painful period, nausea and vomiting was unknown.    No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: severe myalgia all over my body; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number:ER8727), via an unspecified route of administration as a single dose in the left arm on 19Mar2021 at 16:30 as a single dose for COVID-19 immunisation. Relevant medical history included menopause, high cholesterol, OA (osteoarthritis). Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN), both for unknown indication from on an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203), via an unspecified route of administration in the left arm on 26Feb2021 at 10:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 10:00, about 18 hours after vaccination, the patient experienced severe myalgia all over the body. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient took ibuprofen 400 (mg) twice, separated by about 6 hours as a treatment for reported event. The clinical outcome of the event myalgia was resolved on an unknown date. No follow-up attempts are needed. No further information is expected.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on face; This is a spontaneous report received from a contactable consumer, for patient. A 79-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on left arm on16Feb2021 at 15:30 (at the age of 79-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient took several prescriptions but did not had the list as concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on left arm on 26Jan2021 at 13:30 as a single dose for COVID-19 immunisation. It was unknown whether the patient had any allergies to food, medications or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Mar2021 at 22:00 the patient experienced shingles on face unsure if at all connected to vaccination. The patient did received treatment for the reported events and the medication was unknown. The adverse event resulted in a visit to the doctors or other healthcare professional office/clinic visit. The clinical outcome of the event shingles on face was resolving at the time of this report.   Information about lot number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, Sneezing
Clinical narrative: Runny nose; Sneezing; This is a spontaneous report from a contactable consumer, the patient. A 61-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unknown route of administration in right arm on 20Mar2021 at 12:30 (at age of 61-years-old) as single dose for COVID-19 immunisation. The patient had no medical history. The concomitant medications included multi-vitamins (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), vitamin d3 (MANUFACTURER UNKNOWN), biotin (MANUFACTURER UNKNOWN), vitamin b-complex (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 21Mar2021 at 13:00, the patient experienced besides arm, had a runny nose and sneezing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of runny nose and sneezing were not recovered at the time of this report.   Information about lot number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood glucose, Blood glucose increased, Chills, Hyperhidrosis
Clinical narrative: Sweating and soaked clothes; Increase blood sugar; very bad muscle pain; very bad Joint  pain; chills; Swollen in the arm and fingers; Nauseated; This is a spontaneous report from a contactable pharmacist. A 52-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via intramuscular in the left arm on 20Mar2021, as a single dose for COVID-19 immunisation. The patient did not have medical history. The patient was allergic to codeine. Concomitant medications included vitamin c (MANUFACTURER UNKNOWN) and vitamin d (MANUFACTURER UNKNOWN) from unspecified date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via intramuscular in the left arm on 28Feb2021, as a single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient underwent blood sugar test and result was found to be increased. On 21Mar2021, the patient experienced chills, increased blood sugar, nauseated, sweating and soaked clothes, swollen in the arm and fingers, very bad joint pain and muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The treatment for the reported events included hot shower, applied voltaren, eating lemon, drinking ginger tea, and ultramarine between ibuprofen. The clinical outcome of the events chills, increased blood sugar, nauseated, sweating and soaked clothes, swollen in the arm and fingers, very bad joint pain and muscle pain were recovering at time of this report.  Information about lot number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Peripheral swelling
Clinical narrative: Sweating and soaked clothes; Increase blood sugar; very bad muscle pain; very bad Joint  pain; chills; Swollen in the arm and fingers; Nauseated; This is a spontaneous report from a contactable pharmacist. A 52-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via intramuscular in the left arm on 20Mar2021, as a single dose for COVID-19 immunisation. The patient did not have medical history. The patient was allergic to codeine. Concomitant medications included vitamin c (MANUFACTURER UNKNOWN) and vitamin d (MANUFACTURER UNKNOWN) from unspecified date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via intramuscular in the left arm on 28Feb2021, as a single dose for COVID-19 immunisation. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient underwent blood sugar test and result was found to be increased. On 21Mar2021, the patient experienced chills, increased blood sugar, nauseated, sweating and soaked clothes, swollen in the arm and fingers, very bad joint pain and muscle pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The treatment for the reported events included hot shower, applied voltaren, eating lemon, drinking ginger tea, and ultramarine between ibuprofen. The clinical outcome of the events chills, increased blood sugar, nauseated, sweating and soaked clothes, swollen in the arm and fingers, very bad joint pain and muscle pain were recovering at time of this report.  Information about lot number cannot be obtained. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Hypoaesthesia, Malaise
Clinical narrative: Transient numbness; Skin on outside of throat got white; Soreness on outside of throat; Felt chills; Felt lousy; Shaking; Weak; Tired; Nausea; This is a spontaneous report from a contactable health care professional, the pharmacist. A 71-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) intramuscularly in left arm on 13Mar2021 at 18:30 (at an age of 71-years-old) as first single dose for COVID-19 immunisation. Medical history included carotid artery disease and CVS. It was unknown if the patient had any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included TOPROL XL, CRESTOR, PLAVIX for an unknown indication. On 13Mar2021, couple of hours after receiving vaccine, the patient experienced soreness on outside of throat. On 14Mar2021, the patient experienced transient numbness and skin on outside of throat got white. On an unknown date in Mar2021, few days later, the patient experienced chills, felt lousy, shaking, weak, tired and nausea. The patient did not receive any treatment for the events. The clinical outcome of soreness on outside of throat was recovered on 13Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of transient numbness and skin on outside of throat got white was recovered on 14Mar2021. The clinical outcome of chills, felt lousy, shaking, weak, tired and nausea were recovered on an unknown date.   Information about lot number cannot be obtained. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Oropharyngeal pain, Skin discolouration, Tremor
Clinical narrative: Transient numbness; Skin on outside of throat got white; Soreness on outside of throat; Felt chills; Felt lousy; Shaking; Weak; Tired; Nausea; This is a spontaneous report from a contactable health care professional, the pharmacist. A 71-years-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) intramuscularly in left arm on 13Mar2021 at 18:30 (at an age of 71-years-old) as first single dose for COVID-19 immunisation. Medical history included carotid artery disease and CVS. It was unknown if the patient had any allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included TOPROL XL, CRESTOR, PLAVIX for an unknown indication. On 13Mar2021, couple of hours after receiving vaccine, the patient experienced soreness on outside of throat. On 14Mar2021, the patient experienced transient numbness and skin on outside of throat got white. On an unknown date in Mar2021, few days later, the patient experienced chills, felt lousy, shaking, weak, tired and nausea. The patient did not receive any treatment for the events. The clinical outcome of soreness on outside of throat was recovered on 13Mar2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of transient numbness and skin on outside of throat got white was recovered on 14Mar2021. The clinical outcome of chills, felt lousy, shaking, weak, tired and nausea were recovered on an unknown date.   Information about lot number cannot be obtained. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Joint stiffness, Paraesthesia
Clinical narrative: Face tingling/numbness and stiff jaw for ~2 hours after the vaccination.; Face tingling; stiff jaw; This is a spontaneous report received from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264) via an unspecified route of administration in the left arm on 21Mar2021 at 14:30 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. The patients medical history included hashimotos disease. Concomitant medications were included synthroid (MANUFACTURER UNKNOWN), nature throid (MANUFACTURER UNKNOWN) and junel (MANUFACTURER UNKNOWN) all for an unknown indication and from an unknown date. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The facility where the patient received the vaccine was at a pharmacy or drug store. On 21Mar2021 at 14:30, the patient experienced face tingling/numbness and stiff jaw for approximately 2 hours after the vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was received for the events. The clinical outcome for the events face tingling/numbness and stiff jaw was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Contusion, Fatigue, Headache
Clinical narrative: Headache; Tingling through out different parts of body; Fatigue; Fever; Numbness; Bruising on  left hand; Severe chills; This is a spontaneous report received from a contactable consumer, the patient. A 62-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration on left arm on 22Mar2021 at 11:00 as a single dose (at the age of 62 year) for COVID-19 immunisation. The patient medical history and concomitant medication details was not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. On 22Mar2021, the patient experienced severe chills, head ache, numbness and tingling throughout different parts of body, fatigue and bruising on left hand, fever as high as 101 for 2 days with symptoms until the following Sunday. The patient reported temperature 101 (unit not specified) on 22Jan2021 and on unknown date, COVID-19 virus test was performed and was tested positive prior to vaccination. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The clinical outcome of the events severe chills, head ache, numbness and tingling throughout different parts of body, fatigue and bruising on left hand was not recovered at the time of this report and the outcome of the event fever was recovered with sequalae on 28Mar2021.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Pyrexia, SARS-CoV-2 test
Clinical narrative: Headache; Tingling through out different parts of body; Fatigue; Fever; Numbness; Bruising on  left hand; Severe chills; This is a spontaneous report received from a contactable consumer, the patient. A 62-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via unspecified route of administration on left arm on 22Mar2021 at 11:00 as a single dose (at the age of 62 year) for COVID-19 immunisation. The patient medical history and concomitant medication details was not provided. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient was not tested for COVID-19. On 22Mar2021, the patient experienced severe chills, head ache, numbness and tingling throughout different parts of body, fatigue and bruising on left hand, fever as high as 101 for 2 days with symptoms until the following Sunday. The patient reported temperature 101 (unit not specified) on 22Jan2021 and on unknown date, COVID-19 virus test was performed and was tested positive prior to vaccination. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The clinical outcome of the events severe chills, head ache, numbness and tingling throughout different parts of body, fatigue and bruising on left hand was not recovered at the time of this report and the outcome of the event fever was recovered with sequalae on 28Mar2021.   No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Oropharyngeal pain, Pyrexia, Vaccination site pain
Clinical narrative: Sore throat; Swollen lymph nodes; injection site sore; fever; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in the left arm on 20Mar2021 at 10:15 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included WELLBUTRIN. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 20Mar2021, the patient experienced fatigue, fever, vaccination site pain, sore throat, swollen lymph nodes. The patient did not receive treatment for the reported events. The clinical outcome of the events fatigue, fever, vaccination site pain, sore throat, swollen lymph nodes was not recovered at the time of this report.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain
Clinical narrative: Body aches; Tiredness; Chills; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, Lot number: EP6955) via an unspecified route of administration on the left arm on 18Mar2021 at 09:00 (at the age of 32-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not tested positive for COVID-19. On 18Mar2021 at 13:00, the patient experienced body aches, tiredness and chills that began approximately 4 hours after the vaccine and lasted approximately 12 hours. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events body aches, tiredness and chills was recovered at the time of this report.   No follow-up attempts are needed. No further information is expected
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore arm; fatigue; This is a spontaneous report from a contactable other healthcare professional, the patient. A 53-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6207) via unspecified route of administration in the left arm on 21Mar2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included depression/anxiety, psoriasis. No known allergies were reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within 4 weeks prior to the vaccine. Medications received in two weeks included vitamins (MANUFACTURER UNKNOWN), TRINTELLIX, trazadone (MANUFACTURER UNKNOWN), melatonin (MANUFACTURER UNKNOWN) all for unknown indications and from unknown dates. Since the vaccination, the patient had not been tested for COVID-19. On 21Mar2021 at 20:45, patient experienced sore arm, fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the events sore arm, fatigue. The clinical outcome of the events sore arm, fatigue were not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Pruritus, Swelling face, Throat irritation
Clinical narrative: itchiness of face and upper boy(abdomen, back, arms, neck);; redness on the face; itchy throat; headache; swelling of the face (eyes,nose, lips); This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: EN6208), via an unspecified route of administration in the left arm on 21Mar2021 at 10:30 (at the age of 53-year-old) as single dose for COVID-19 immunisation. Medical history included sickle cell, fibromyalgia, asthma. The patient was allergic to sulfa drugs. The patient had not received any medications in two weeks prior vaccination. The patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22Mar2021, the patient experienced minor itchiness of face and upper body (abdomen, back, arms, neck), slight redness on the face, itchy throat, headache and swelling of the face (eyes, nose, lips). The clinical outcome of the events itching, redness of face, itchy throat, headache and swelling of the face were unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: Glands under arm sore and swollen days after vaccine; Glands under arm sore and swollen days after vaccine; This is a spontaneous report from a contactable consumer or other non health care professional (patient) via Pfizer Sales Representative. A 48-year-old female patient received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number and Expiration date not reported), via an unspecified route of administration in an unspecified anatomical location on an unspecified date (at the age of 48-year-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced glands under arm sore and swollen days after vaccine on an unspecified date. The outcome of all events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.